A Study to Evaluate Diarrhea in Patients with Multiple Myeloma Receiving Conditioning Chemotherapy for Autologous Stem Cell Transplantation (SCT)

Overview

About this study

The purpose of this study is to evaluate the changes in bowel movements in patients with multiple myeloma receiving conditioning cheomotherapy for autologous stem cell transplantation (SCT).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Age ≥18 years, male or female
Diagnosis: multiple myeloma undergoing Autologous Stem Cell Transplantation (SCT)
Planning to receive conditioning chemotherapy with Melphalan (140 – 200 mg/m2) alone for autologous stem cell transplantation and standard prophylactic antibiotics treatment.
Can drink 200ml of mannitol and agrees to undergo stool, urine, and blood checks 3 times during the study.

Exclusion Criteria:

Patients with history of inflammatory bowel disease will be excluded from the study.
Patients with prior GI tract surgical (small or large bowel) resections
The concurrent presence of systemic light chain amyloidosis
Women who are pregnant or breast-feeding
Presence of any condition that the Investigator believes would put the subject at risk or would preclude the patient from successfully completing all aspects of the trial.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Michael Camilleri, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Michael Camilleri, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials